| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP1427704B1 Method for producing 4-haloalkylnicotinic acid esters |
| 02/09/2005 | EP1368315A4 Method for preparing amlodipine |
| 02/09/2005 | EP0941093B1 Use of nk-1 receptor antagonists for treating major depressive disorders with anxiety |
| 02/09/2005 | CN1578767A Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/08/2005 | US6852860 Method for making piperidone ketals using polyphosphoric acid |
| 02/08/2005 | US6852761 Inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular |
| 02/08/2005 | US6852752 Urea compounds, compositions and methods of use and preparation |
| 02/08/2005 | US6852742 To modulate the activity of calcium channels, therapy of cardiovascular disease or neurological disorders, that are associated with calcium channels |
| 02/08/2005 | US6852738 Potent ligands for PPAR gamma and generally have antagonist or partial agonist activity. The compoundsare for treatment, control or prevention of obesity, non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, |
| 02/08/2005 | US6852737 Melting point of 150-152 degrees C and 3-4% ethyl acetate; antihypertensive agents |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/05/2005 | CA2475665A1 Methods for making carboxylated pulp fibers |
| 02/03/2005 | WO2005009960A1 Method for purification of amlodipine free base |
| 02/03/2005 | WO2005009959A1 Piperidine derivatives as ccr5 receptor modulators |
| 02/03/2005 | WO2005009944A1 Prodrugs of 9-aminomethyl tetracycline compounds |
| 02/03/2005 | WO2005009941A1 Indane derivates as muscarinic receptor agonists |
| 02/03/2005 | WO2004054581A3 Cyclohexyl compounds as ccr5 antagonists |
| 02/03/2005 | WO2004011427A3 Substituted benzanilides as modulators of the ccr5 receptor |
| 02/03/2005 | US20050026956 Carbinols for the treatment of neuropathic dysfunction |
| 02/03/2005 | US20050026955 Radiolabeled piperidine derivatives; chelate compounds; complexes with technetium |
| 02/03/2005 | US20050026928 Chemical compounds |
| 02/03/2005 | US20050026895 Having a superior acetylcholinesterase inhibitory action; treatment of Alzheimer's disease, brain disorders, attention deficit disorders; side effect reduction |
| 02/03/2005 | US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke |
| 02/03/2005 | DE19816479B4 Verfahren zur Herstellung von Enaminen, Iminen, Indolen und Diaminen aus Alkinen und deren Weiterverarbeitung durch katalytische Hydrierung Process for the preparation of enamines, imines, indoles and diamines from alkynes and their further processing by catalytic hydrogenation |
| 02/03/2005 | DE10335092B3 Substituierte Benzoylureido-o-benzoylamide, Verfahren zu deren Herstellung und deren Verwendung Benzoylureido substituted-o-benzoylamide, processes for their preparation and their use |
| 02/03/2005 | DE10001208B4 Verfahren zur homogen-katalytischen Hydroaminierung von Alkinen für die Herstellung von Enaminen, Iminen, Indolen und Diaminen und deren Weiterverarbeitung durch katalytische Hydrierung Process for the catalytic hydroamination of alkynes homogeneous for the production of enamines, imines, indoles and diamines and their processing by catalytic hydrogenation |
| 02/03/2005 | CA2744317A1 Substituted tetracycline compounds |
| 02/03/2005 | CA2532816A1 Method for purification of amlodipine free base |
| 02/03/2005 | CA2530087A1 Radiolabeled cannabinoid-1 receptor modulators |
| 02/03/2005 | CA2529036A1 Indane derivates as muscarinic receptor agonists |
| 02/02/2005 | EP1502576A2 Composition containing a 2-thioacetamide and use thereof for stimulating growth or preventing fall out of keratin fibres |
| 02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
| 02/02/2005 | EP1501814A1 Semicarbazide derivatives for combating thromboembolic diseases |
| 02/02/2005 | EP1501800A1 Bombesin antagonists |
| 02/02/2005 | EP1501799A1 Compounds useful in preparing camptothecin derivatives |
| 02/02/2005 | EP1501798A2 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS |
| 02/02/2005 | EP1501513A2 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 02/02/2005 | EP1501510A1 The treatment of pain with ifenprodil |
| 02/02/2005 | EP1501467A2 Heterocyclo inhibitors of potassium channel function |
| 02/02/2005 | EP1379587B1 Long chain hindered amines and compositions stabilized therewith |
| 02/02/2005 | EP0828754B1 Dipeptides which promote release of growth hormone |
| 02/02/2005 | CN1575279A Substituted thioacetamides |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575172A Substituted ideno[1, 2-c]isoquinoline derivatives and methods of use thereof |
| 02/02/2005 | CN1572882A Benzamidine derivatives |
| 02/02/2005 | CN1572788A Cycloheximide |
| 02/02/2005 | CN1572299A Agents for improving excretory potency of urinary bladder |
| 02/02/2005 | CN1187342C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 02/02/2005 | CN1187331C Esters of 3-hydroxy-piperidinemethanol derivatives, pharmaceutical composition containing same and their preparation method and uses |
| 02/02/2005 | CN1187327C Method for production of N-alkenyl amides |
| 02/02/2005 | CN1187326C Novel compounds |
| 02/01/2005 | US6849766 Such as 1,4-diamino-2-styrylbenzene; hair/oxidation color dyes |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849626 Aza-amino acid derivatives (factor Xa inhibitors 15) |
| 02/01/2005 | US6849621 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 02/01/2005 | US6849597 Administering a growth hormone secretagogue to a mammal, for preventing nerve cells degeneration or death of neurons |
| 02/01/2005 | CA2257095C Process for purifying sterically hindered 4-amino piperidines |
| 01/27/2005 | WO2005007629A1 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | WO2005007161A1 Remedy for pruritus comprising piperidine derivative as the active ingredient |
| 01/27/2005 | WO2004108673A3 Inhibitors of papilloma virus |
| 01/27/2005 | WO2004069794B1 New arylpiperazinyl compounds |
| 01/27/2005 | WO2004064972A3 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 01/27/2005 | US20050020838 Acetylenic compound useful in treating inflammatory disorders |
| 01/27/2005 | US20050020648 "PGI2-preferring" (IP) receptors; p-(imidazolin-2-ylamino-optional alkyl)phenyl p'-substituted ethers or sulfides, e.g., 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-phenylsulfanyl)-phenyl]-amine, used to induce hyperalgesia |
| 01/27/2005 | US20050020629 Pain management |
| 01/27/2005 | US20050020628 Piperidine derivatives and process for their production |
| 01/27/2005 | US20050020562 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 01/26/2005 | EP1500648A1 Novel piperidine derivative |
| 01/26/2005 | EP1500643A1 Benzamide derivatives |
| 01/26/2005 | EP1499898A2 Regulation of tnf-alpha |
| 01/26/2005 | EP1499596A1 Muscarinic antagonists |
| 01/26/2005 | EP1499592A1 Amlodipine nicotinate and process for the preparation thereof |
| 01/26/2005 | EP1499591A1 Carboxylic acid amides |
| 01/26/2005 | EP1499590A1 Novel compounds |
| 01/26/2005 | EP1499589A1 Derivatives of n-phenyl(piperidin-2-yl)methyl benzamide, the preparation method thereof and application of same in therapeutics |
| 01/26/2005 | EP1499588A1 Melanocortin receptor ligands |
| 01/26/2005 | EP1499314A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
| 01/26/2005 | EP1499313A2 Heterocyclic derivatives as opioid receptor modulators |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | CN1571785A Synthesis of 4-[(z)-4-bromophenyl)(ethoxyimino) methyl]-1'-[(2, 4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'-methyl-1, 4-'bipiperidine |
| 01/26/2005 | CN1571784A Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 01/26/2005 | CN1571782A Piperidine- and piperazineacetamines as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/26/2005 | CN1571770A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/26/2005 | CN1571768A Synthesis of (4-bromopnenyl)(4-piperidyl)methanone-(z)-o-ethyloxime and salts |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/26/2005 | CN1186318C Novel benzenesulphonamide compound, its prepn. process and medicinal compsns. contg. them |
| 01/25/2005 | US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/25/2005 | US6846932 Process for preparation of chiral amlodipine salts |
| 01/25/2005 | US6846931 Organic acid salt of amlodipine |
| 01/25/2005 | US6846835 Treating chronic obstructive pulmonary disease, chronic bronchitis, asthma, chronic respiratory tract obstruction, fibroid lung, pulmonary emphysema or rhinitis |
| 01/25/2005 | US6846825 Antibacterial agents |
| 01/25/2005 | US6846817 Nicotine receptor ligands |
| 01/25/2005 | US6846813 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits |